Be the first to like this
A number of macroeconomic and regulatory events came to a head in 2010, resulting in a significant period of transition for the vast majority of major medical technology manufacturers. The ramifications of those shifts are evidenced in the rebooted market strategies and overhauled organizational structures of medical device companies looking to better adapt to a changing market landscape.
In 2013 and moving forward, most market participants have similar goals of controlling costs, positioning business in growing treatment areas, and expanding the organization’s footprint in emerging markets. Given continued industry pressures and headwinds, the execution of strategies to achieve those goals is paramount to long-term market viability.
Listen to the on-demand webinar on this topic: https://www.frost.com/prod/servlet/analyst-briefing-detail.pag?mode=open&sid=275002068